• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性肝病中与蛋白质 - 能量营养不良相关的因素:使用间接测热法的分析

Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry.

作者信息

Nishikawa Hiroki, Yoh Kazunori, Enomoto Hirayuki, Iwata Yoshinori, Kishino Kyohei, Shimono Yoshihiro, Hasegawa Kunihiro, Nakano Chikage, Takata Ryo, Nishimura Takashi, Aizawa Nobuhiro, Sakai Yoshiyuki, Ikeda Naoto, Takashima Tomoyuki, Ishii Akio, Iijima Hiroko, Nishiguchi Shuhei

机构信息

From the Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine, Hyogo College of Medicine, Hyogo, Japan.

出版信息

Medicine (Baltimore). 2016 Jan;95(2):e2442. doi: 10.1097/MD.0000000000002442.

DOI:10.1097/MD.0000000000002442
PMID:26765430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4718256/
Abstract

We aimed to elucidate the incidence of protein-energy malnutrition (PEM) in patients with chronic liver disease and to identify factors linked to the presence of PEM.A total of 432 patients with chronic liver disease were analyzed in the current analysis. We defined patients with serum albumin level of ≤3.5 g/dL and nonprotein respiratory quotient (npRQ) value using indirect calorimetry less than 0.85 as those with PEM. We compared between patients with PEM and those without PEM in baseline characteristics and examined factors linked to the presence of PEM using univariate and multivariate analyses.There are 216 patients with chronic hepatitis, 123 with Child-Pugh A, 80 with Child-Pugh B, and 13 with Child-Pugh C. Six patients (2.8%) had PEM in patients with chronic hepatitis, 17 (13.8%) in patients with Child-Pugh A, 42 (52.5%) in patients with Child-Pugh B, and 10 (76.9%) in patients with Child-Pugh C (P < 0.001). Multivariate analysis revealed that Child-Pugh classification (P < 0.001), age ≥64 years (P = 0.0428), aspartate aminotransferase (AST) ≥40 IU/L (P = 0.0023), and branched-chain amino acid to tyrosine ratio (BTR) ≤5.2 (P = 0.0328) were independent predictors linked to the presence of PEM. On the basis of numbers of above risk factors (age, AST, and BTR), the proportions of patients with PEM were well stratified especially in patients with early chronic hepatitis or Child-Pugh A (n = 339, P < 0.0001), while the proportions of patients with PEM tended to be well stratified in patients with Child-Pugh B or C (n = 93, P = 0.0673).Age, AST, and BTR can be useful markers for identifying PEM especially in patients with early stage of chronic liver disease.

摘要

我们旨在阐明慢性肝病患者中蛋白质 - 能量营养不良(PEM)的发生率,并确定与PEM存在相关的因素。本分析共纳入432例慢性肝病患者。我们将血清白蛋白水平≤3.5 g/dL且通过间接测热法测得的非蛋白呼吸商(npRQ)值小于0.85的患者定义为患有PEM。我们比较了PEM患者和非PEM患者的基线特征,并使用单因素和多因素分析检查了与PEM存在相关的因素。有216例慢性肝炎患者,123例Child-Pugh A级患者,80例Child-Pugh B级患者和13例Child-Pugh C级患者。慢性肝炎患者中有6例(2.8%)患有PEM,Child-Pugh A级患者中有17例(13.8%),Child-Pugh B级患者中有42例(52.5%),Child-Pugh C级患者中有10例(76.9%)(P < 0.001)。多因素分析显示,Child-Pugh分级(P < 0.001)、年龄≥64岁(P = 0.0428)、天冬氨酸转氨酶(AST)≥40 IU/L(P = 0.0023)以及支链氨基酸与酪氨酸比值(BTR)≤5.2(P = 0.0328)是与PEM存在相关的独立预测因素。基于上述风险因素(年龄、AST和BTR)的数量,PEM患者的比例得到了很好的分层,尤其是在早期慢性肝炎患者或Child-Pugh A级患者中(n = 339,P < 0.0001),而在Child-Pugh B级或C级患者中PEM患者的比例也倾向于得到很好的分层(n = 93,P = 0.0673)。年龄、AST和BTR可作为识别PEM的有用标志物,尤其是在慢性肝病早期患者中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/021f946982eb/medi-95-e2442-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/008f20f53733/medi-95-e2442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/354e308e0007/medi-95-e2442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/11f4b078e893/medi-95-e2442-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/021f946982eb/medi-95-e2442-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/008f20f53733/medi-95-e2442-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/354e308e0007/medi-95-e2442-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/11f4b078e893/medi-95-e2442-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9255/4718256/021f946982eb/medi-95-e2442-g005.jpg

相似文献

1
Factors Associated With Protein-energy Malnutrition in Chronic Liver Disease: Analysis Using Indirect Calorimetry.慢性肝病中与蛋白质 - 能量营养不良相关的因素:使用间接测热法的分析
Medicine (Baltimore). 2016 Jan;95(2):e2442. doi: 10.1097/MD.0000000000002442.
2
Serum hyaluronic acid predicts protein-energy malnutrition in chronic hepatitis C.血清透明质酸可预测慢性丙型肝炎患者的蛋白质能量营养不良。
Medicine (Baltimore). 2016 Jun;95(24):e3920. doi: 10.1097/MD.0000000000003920.
3
Serum proinflammatory cytokines and nutritional status in pediatric chronic liver disease.小儿慢性肝病患者的血清促炎细胞因子与营养状况
World J Gastroenterol. 2015 Aug 7;21(29):8927-34. doi: 10.3748/wjg.v21.i29.8927.
4
Indirect calorimetry and anthropometry to estimate energy metabolism in patients with liver cirrhosis.间接测热法和人体测量法用于评估肝硬化患者的能量代谢。
J Nutr Sci Vitaminol (Tokyo). 2010;56(6):372-9. doi: 10.3177/jnsv.56.372.
5
Prognostic significance of low skeletal muscle mass compared with protein-energy malnutrition in liver cirrhosis.肝硬化中低骨骼肌质量与蛋白质 - 能量营养不良相比的预后意义
Hepatol Res. 2017 Sep;47(10):1042-1052. doi: 10.1111/hepr.12843. Epub 2017 Jan 17.
6
Prognostic significance of nonprotein respiratory quotient in patients with liver cirrhosis.非蛋白呼吸商在肝硬化患者中的预后意义
Medicine (Baltimore). 2017 Jan;96(3):e5800. doi: 10.1097/MD.0000000000005800.
7
Low birth weight as a determinant of protein energy malnutrition in "0-5 years" Omani children of South Batinah region, Oman.低出生体重作为阿曼南巴提奈地区“0至5岁”阿曼儿童蛋白质能量营养不良的一个决定因素。
Saudi Med J. 2004 Aug;25(8):1091-6.
8
Protein-energy malnutrition as the first manifestation of cystic fibrosis in infancy.蛋白质-能量营养不良作为婴儿期囊性纤维化的首发表现。
Pediatr Int. 2009 Oct;51(5):678-83. doi: 10.1111/j.1442-200X.2009.02855.x. Epub 2009 Mar 20.
9
Serum Zinc Level and non-Protein Respiratory Quotient in Patients with Chronic Liver Diseases.慢性肝病患者的血清锌水平与非蛋白呼吸商
J Clin Med. 2020 Jan 17;9(1):255. doi: 10.3390/jcm9010255.
10
The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis.慢性丙型肝炎病毒相关肝硬化患者控制营养(CONUT)评分与临床标志物的关系。
Nutrients. 2018 Aug 29;10(9):1185. doi: 10.3390/nu10091185.

引用本文的文献

1
Inflammatory sarcopenia, a novel concept in chronic liver disease: insights from magnetic resonance imaging biomarkers.炎症性肌肉减少症,慢性肝病中的一个新概念:来自磁共振成像生物标志物的见解
Transl Gastroenterol Hepatol. 2025 Apr 23;10:50. doi: 10.21037/tgh-24-120. eCollection 2025.
2
Nutritional assessment using subjective global assessment identifies energy malnutrition and predicts mortality in patients with liver cirrhosis.采用主观全面评定法进行营养评估可识别肝硬化患者的能量营养不良情况并预测其死亡率。
Sci Rep. 2025 Feb 9;15(1):4831. doi: 10.1038/s41598-025-89803-6.
3
Prognostic Nutritional Index Correlates with Liver Function and Prognosis in Chronic Liver Disease Patients.

本文引用的文献

1
Impact of body mass index on in-hospital complications in patients undergoing percutaneous coronary intervention in a Japanese real-world multicenter registry.日本真实世界多中心注册研究中体重指数对接受经皮冠状动脉介入治疗患者院内并发症的影响。
PLoS One. 2015 Apr 14;10(4):e0124399. doi: 10.1371/journal.pone.0124399. eCollection 2015.
2
Nutrition in the management of cirrhosis and its neurological complications.肝硬化及其神经并发症管理中的营养
J Clin Exp Hepatol. 2014 Jun;4(2):141-50. doi: 10.1016/j.jceh.2013.05.008. Epub 2013 Jun 11.
3
Sarcopenia impairs prognosis of patients with liver cirrhosis.
预后营养指数与慢性肝病患者的肝功能及预后相关。
Diagnostics (Basel). 2023 Dec 25;14(1):49. doi: 10.3390/diagnostics14010049.
4
Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.酒精性肝病不同阶段的临床、组织学和分子特征分析。
Gut. 2022 Sep;71(9):1856-1866. doi: 10.1136/gutjnl-2021-324295. Epub 2022 Jan 6.
5
Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact.肝硬化患者的肌肉减少性肥胖:可能的机制和临床影响。
Int J Mol Sci. 2021 Feb 15;22(4):1917. doi: 10.3390/ijms22041917.
6
Evaluation of the efficacy of chlorogenic acid in reducing small intestine injury, oxidative stress, and inflammation in chickens challenged with Clostridium perfringens type A.评估绿原酸对 A 型产气荚膜梭菌攻毒致鸡小肠损伤、氧化应激及炎症的疗效。
Poult Sci. 2020 Dec;99(12):6606-6618. doi: 10.1016/j.psj.2020.09.082. Epub 2020 Oct 6.
7
Late-Evening Snack with Branched-Chain Amino Acid-Enriched Nutrients Does Not Always Inhibit Overt Diabetes in Patients with Cirrhosis: A Pilot Study.富含支链氨基酸的营养物质的晚间零食并不总是能抑制肝硬化患者的显性糖尿病:一项初步研究。
Nutrients. 2019 Sep 7;11(9):2140. doi: 10.3390/nu11092140.
8
The Relationship between Controlling Nutritional (CONUT) Score and Clinical Markers among Adults with Hepatitis C Virus Related Liver Cirrhosis.慢性丙型肝炎病毒相关肝硬化患者控制营养(CONUT)评分与临床标志物的关系。
Nutrients. 2018 Aug 29;10(9):1185. doi: 10.3390/nu10091185.
9
Rapidly declining skeletal muscle mass predicts poor prognosis of hepatocellular carcinoma treated with transcatheter intra-arterial therapies.骨骼肌量迅速下降预示经导管肝动脉内治疗的肝细胞癌预后不良。
BMC Cancer. 2018 Jul 24;18(1):756. doi: 10.1186/s12885-018-4673-2.
10
Relationship between skeletal muscle mass and liver fibrosis markers for patients with hepatitis C virus related liver disease.丙型肝炎病毒相关肝病患者骨骼肌质量与肝纤维化标志物之间的关系。
Medicine (Baltimore). 2017 Dec;96(48):e8761. doi: 10.1097/MD.0000000000008761.
肌肉减少症会损害肝硬化患者的预后。
Nutrition. 2015 Jan;31(1):193-9. doi: 10.1016/j.nut.2014.07.005. Epub 2014 Jul 30.
4
Serum zinc value in patients with hepatitis virus-related chronic liver disease: association with the histological degree of liver fibrosis and with the severity of varices in compensated cirrhosis.血清锌值与肝炎病毒相关慢性肝病患者的肝纤维化程度及代偿性肝硬化静脉曲张严重程度的相关性。
J Clin Biochem Nutr. 2014 Sep;55(2):147-52. doi: 10.3164/jcbn.14-33. Epub 2014 Jul 26.
5
Clinical relevance of sarcopenia in patients with cirrhosis.肝硬化患者中肌肉减少症的临床相关性。
World J Gastroenterol. 2014 Jul 7;20(25):8061-71. doi: 10.3748/wjg.v20.i25.8061.
6
Nutrition and exercise in the management of liver cirrhosis.肝硬化管理中的营养与运动
World J Gastroenterol. 2014 Jun 21;20(23):7286-97. doi: 10.3748/wjg.v20.i23.7286.
7
Comparison of measured and predicted energy expenditure in patients with liver cirrhosis.肝硬化患者实测与预测能量消耗的比较。
Asia Pac J Clin Nutr. 2014;23(2):197-204. doi: 10.6133/apjcn.2014.23.2.12.
8
Cirrhosis and its complications: evidence based treatment.肝硬化及其并发症:循证治疗
World J Gastroenterol. 2014 May 14;20(18):5442-60. doi: 10.3748/wjg.v20.i18.5442.
9
Liver cirrhosis.肝硬化。
Lancet. 2014 May 17;383(9930):1749-61. doi: 10.1016/S0140-6736(14)60121-5. Epub 2014 Jan 28.
10
NAFLD, NASH and liver cancer.非酒精性脂肪性肝病、非酒精性脂肪性肝炎和肝癌。
Nat Rev Gastroenterol Hepatol. 2013 Nov;10(11):656-65. doi: 10.1038/nrgastro.2013.183. Epub 2013 Oct 1.